Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 02, 2026 16:15 ET | Source: California Water Service Group

California Water Service Group Earns Spot on Newsweek’s “Most Trustworthy Companies in America” List for Fourth Time

SAN JOSE, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- In recognition of the company’s integrity and strong corporate values, Newsweek magazine has named California Water Service Group (Group) (NYSE:...
April 02, 2026 16:12 ET | Source: United Steelworkers union

Steelworkers union enlightens space agencies on labour conditions behind Artemis II moon mission’s maple syrup

Maple syrup workers “are not asking for the moon. They are asking for respect,” union tells space agencies.
April 02, 2026 16:05 ET | Source: Akebia Therapeutics, Inc.

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., April 02, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease,...
April 02, 2026 16:05 ET | Source: Encore Capital Group, Inc.

Encore Capital Group to Announce First Quarter 2026 Financial Results on May 6

SAN DIEGO, April 02, 2026 (GLOBE NEWSWIRE) -- Encore Capital Group, Inc. (Nasdaq:ECPG), an international specialty finance company, announced today that it will release its financial results for the...
April 02, 2026 16:05 ET | Source: Fate Therapeutics, Inc.

Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, April 02, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced...
April 02, 2026 16:05 ET | Source: Candel Therapeutics

Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEEDHAM, Mass., April 02, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal...
April 02, 2026 16:05 ET | Source: ACM Research, Inc.

ACM Research Introduces ACM Planetary Family™ Product Portfolio Structure

FREMONT, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- ACM Research, Inc. (“ACM”) (NASDAQ: ACMR), a leading supplier of wafer and panel processing solutions for semiconductor and advanced packaging...
April 02, 2026 16:05 ET | Source: Athyrium Capital Management, LP

Athyrium Capital Management and Esperion Enter Into $50 Million Japan Royalty Financing to Support Strategic Acquisition of Corstasis Therapeutics

Athyrium Funds purchased a portion of the royalties payable to Esperion on Japan net sales of Otsuka’s bempedoic acid products, together with related milestone payments, subject to a cap, for total...
April 02, 2026 16:05 ET | Source: PennantPark Investment Corporation

PennantPark Investment Corporation Announces Monthly Distribution of $0.08 per Share

MIAMI, April 02, 2026 (GLOBE NEWSWIRE) -- PennantPark Investment Corporation (the "Company") (NYSE: PNNT) declares its monthly distribution for April 2026 of $0.08 per share, comprised of a $0.04...
April 02, 2026 16:05 ET | Source: PennantPark Floating Rate Capital Ltd.

PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.1025 per Share

MIAMI, April 02, 2026 (GLOBE NEWSWIRE) -- PennantPark Floating Rate Capital Ltd. (the "Company") (NYSE: PFLT) declares its monthly distribution for April 2026 of $0.1025 per share, payable on May 1,...